A Message from Vice President of Mundipharma Middl
Post# of 7813
(Total Views: 401)
Posted On: 12/30/2019 11:05:51 AM
A Message from Vice President of Mundipharma Middle East, Turkey & Africa Region
The Middle East, Turkey and Africa Region (META) is one of the fastest growing regions for Mundipharma in the world.
Our vision is to build and sustain Mundipharma as ‘’One of the most admired and valued pharmaceutical companies” in the META region. We strongly believe that we have built THE best capable and reputable team in the industry who can drive our successful growth journey and make this happen.
Through working in partnership with key stakeholders from health care providers to regulatory authorities, pharmacists and distributors, our goal is to ensure that patients in the Middle East, Turkey & Africa have access to cost-effective innovative treatments and the best possible quality of affordable health care.
We are committed to addressing and solving the most important unmet medical needs. Our product portfolio creates an indispensable presence in the areas of pain management , respiratory, consumer health, oncology, ophthalmology and other specialty areas.
https://www.mundipharma.ae/presidents-message
11/4/2019 Investor Update
"We are also working to finalize discussions with MundiPharma for adding up to 30 countries in the MENA region."
The Middle East, Turkey and Africa Region (META) is one of the fastest growing regions for Mundipharma in the world.
Our vision is to build and sustain Mundipharma as ‘’One of the most admired and valued pharmaceutical companies” in the META region. We strongly believe that we have built THE best capable and reputable team in the industry who can drive our successful growth journey and make this happen.
Through working in partnership with key stakeholders from health care providers to regulatory authorities, pharmacists and distributors, our goal is to ensure that patients in the Middle East, Turkey & Africa have access to cost-effective innovative treatments and the best possible quality of affordable health care.
We are committed to addressing and solving the most important unmet medical needs. Our product portfolio creates an indispensable presence in the areas of pain management , respiratory, consumer health, oncology, ophthalmology and other specialty areas.
https://www.mundipharma.ae/presidents-message
11/4/2019 Investor Update
"We are also working to finalize discussions with MundiPharma for adding up to 30 countries in the MENA region."
(1)
(0)BioElectronics Corporation (BIEL) Stock Research Links
Scroll down for more posts ▼